2Willemze R,Jaffe ES,Burg G,et al.WHO-EORTC classification for cutaneous lymphomas.Blood,2005,105(10):3768-3785.
3Willemze R,Kerl H,Sterry W,et al.EORTC classification for primary cutaneous lymphomas:a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.Blood,1997,90(1):354-371.
4Bekkenk MW,Geelen FA,van Voorst Vader PC,et al.Primary and secondary cutaneous CD30(+)lymphoproliferative disorders:a report from the Dutch Cutaneous Lymphoma Group on the longterm follow-up data of 219 patients and guidelines for diagnosis and treatment.Blood,2000,95(12):3653-3661.
5DeCoteau JF,Butmarc JR,Kinney MC,et al.The t(2;5)chromosomal translocation is not a common feature of primary cutaneous CD30+lymphoproliferative disorders:comparison with anaplastic large-cell lymphoma of nodal origin.Blood,1996,87(8):3437-3441.
6Swerdlow SH,Campo E,Harris NL,et al.World Health Organization classification of tumours.WHO classification of tumours of haematopoietic and lymphoid tissues.Lyon:IARC press,2008:300-301.
7Stein H,Mason DY,Gerdes J,et al.The expression of the Hedgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue:evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid colls.Blood,1985,66(4):848-858.
8Stein H,Foss HD,Durkop H,et al.CD30(+)anaplastic large cell lymphoma:a review of its histepathologic,genetic,and clinical features.Blood,2000,96(12):3681-3695.
9Gascoyne RD,Aoun P,Wu D,et al.Prognostic significance of anaplastic lymphoma kinase(ALK)protein expression in adults with anaplastic large cell lymphoma.Blood,1999,93(11):3913-3921.
10de Bruin PC,Beljaards RC,van Heerde P,et al.Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplustic large cell lymphoma of Tor null cell phenotype.Histopathology,1993,23(2):127-135.
